Log In
BCIQ
Print this Print this
 

JOT101

  Manage Alerts
Collapse Summary General Information
Company Jupiter Orphan Therapeutics Inc.
DescriptionFormulation of pharmaceutical grade trans-resveratrol (RSV)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today